| ICD-10 Code | Description |
| T44.5X1A | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.5X1D | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.5X1S | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.5X2A | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.5X2D | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.5X2S | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.5X3A | Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter |
| T44.5X3D | Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter |
| T44.5X3S | Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela |
| T44.5X4A | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter |
| T44.5X4D | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.5X4S | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela |
| T44.5X5A | Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X5D | Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X5S | Adverse effect of predominantly beta-adrenoreceptor agonists, sequela |
| T44.5X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X6D | Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X6S | Underdosing of predominantly beta-adrenoreceptor agonists, sequela |
